RxDoctor Payments Data

Juan Garcia-Morell, MD

Clinical Cardiac Electrophysiology · Clearwater, FLNPI 1154571560

Payments from drug & device makers

$18,981in general payments, 2019–2025

Across 463 payments — averaging $41.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biosense Webster, Inc.$8K
  • Medtronic$5K
  • Boston Scientific$3K
  • Medical Device Business Services, Inc.$931
  • Abbott$868
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$478
  • plus $992 from 13 others

What the payments were for

  • Consulting fees$5,62530%
  • Travel & lodging$3,03316%
  • Food & beverage$10,24754%
  • Education$770%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,981 in reported general payments places this provider in the 30th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida

Medicare billing

Part B allowed, 2024
$270,614
Medicare patients
1,561
Services billed
4,110

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban227$291,472
XareltoRivaroxaban44$59,864
EntrestoSacubitril/Valsartan21$25,010
Flecainide Acetate127$6,367
Propafenone Hcl ErPropafenone Hcl17$5,471
Dofetilide18$2,927
Metoprolol Succinate133$1,867
Valsartan53$1,147
SotalolSotalol Hcl44$1,089
Amiodarone Hcl54$914
Digoxin27$690
Diltiazem 24hr Er (Cd)Diltiazem Hcl32$647
Nifedipine ErNifedipine11$612
Carvedilol89$581
ClopidogrelClopidogrel Bisulfate41$539

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$12$291,472227 claims
Johnson & JohnsonXarelto$16$59,86444 claims
NovartisEntresto$16$25,01021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 249 clinical cardiac electrophysiology providers in Florida.

Other clinical cardiac electrophysiology in Clearwater

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →